Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.63 |
| ▸ | KIF11 | P52732 | 2/20 | 0.61 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.53 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP2 | O95551 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | MMP12 | P39900 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516986 | 0.88 | KIF11 (0.67) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL28956487 | 0.82 | KIF11 (0.55) | PGRKIF11CYP1A2SIRT2MAPT | |
| SCHEMBL4621040 | 0.81 | KIF11 (0.52) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL3306566 | 0.80 | KIF11 (0.69) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL2061739 | 0.79 | KIF11 (0.56) | PGRKIF11CYP2C9SIRT2MAPT | |
| SCHEMBL3312587 | 0.78 | KIF11 (0.72) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL14865934 | 0.78 | KIF11 (0.68) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL4596554 | 0.78 | KIF11 (0.68) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL4594845 | 0.78 | KIF11 (0.68) | PGRKIF11CYP11B1CYP11B2PDE3B | |
| SCHEMBL3307966 | 0.78 | KIF11 (0.68) | PGRKIF11CYP11B1CYP11B2PDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080176830-A1 | Compounds, Compositions, and Methods | ADAMS NICHOLAS D | 2008-07-24 | — | — | US | claimed |
| US-20080176830-A1 | Compounds, Compositions, and Methods | ADAMS NICHOLAS D | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176830-A1 | Compounds, Compositions, and Methods | ALPP, PCNA, MKI67 | PGR 592/4885KIF11 562/4885CYP11B1 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.